HHS and the Cohen Foundation Name Serimmune a Phase 1 Winner in LymeX Diagnostics Prize

GOLETA, Calif.--(BUSINESS WIRE)--The U.S. Department of Health and Human Services and the Cohen Foundation have selected Serimmune as a Phase 1 winner in the LymeX Diagnostics Prize, a LymeX Innovation Accelerator (LymeX) prize competition to accelerate the development of Lyme disease diagnostics. As a Phase 1 winner, Serimmune will receive...

Click to view original post